Managing Partner of Tian Yuan Law Firm and Head of Tian Yuan Law Firm Hong Kong Office

10/F, Tower B, China Pacific Insurance Plaza
28 Fengsheng Hutong, Xicheng District
Beijing, 100032

(86 10) 5776 3888

Distinguished Practitioner

Chinese and English


Jurisdiction:

China

Practice area:

Capital markets


Since 2018, Mr. Fu has completed 56 IPOs both in the PRC and overseas covering TMT, healthcare, fintech, real estate and other traditional industries, among which, the most significant ones please see below “Recent case highlights”.

Mr. Fu is awarded as “ALB Dealmakers of Asia 2020”, “Leading Individual in Capital Market” by Chambers Asia Pacific and Chambers Global, "Top-tier Lawyer in Capital Markets: Overseas IPO” and “Top-tier Lawyer in Healthcare and Life Sciences” by LEGALBAND, “Leading Lawyer: Overseas IPO” by The Legal 500, “Highly Regarded in Capital Markets” by IFLR1000 in 2021.

  • Bilibili Inc. (BILI.Nasdaq, 9626.HK) - one of the most popular Chinese internet entertainment communities for young people. secondary listing in HK as the first Non-Grandfather Greater China issuer in 2021.
  • Nongfu Spring Co., Ltd (9633.HK) - China’s largest packaging water supplier.
  • Ascletis Pharma Inc. (1672.HK) - the first biotech company listed in HK since the introduction of Chapter 18A of listing rules. Rewarded as “Deal of the Year” in 2018 by China Business Law Journal.
  • Shanghai Junshi Biosciences Co., Ltd. (1877.HK, 688180.SH) - the first NEEQ-listed Chinese company listed in HK and listed in STAR market in 2020.
  • CanSino Biologics Inc. (6185.HK, 688185.SH) - the first H share biotech company listed in HK since the introduction of Chapter 18A of listing rules and listed in STAR market in 2020. Rewarded as “Deal of the Year” in 2019 and 2020 respectively by China Business Law Journal.
  • Hansoh Pharmaceutical Group Company Limited (3692.HK) - the largest pharmaceutical HK IPO in 2019 with fundraising exceeding US$1 billion.
  • Jinxin Fertility Group Limited (1951.HK) - the only medical company listed in HK with market value exceeding HK$20 billion.
  • Hygeia Healthcare Holdings Co., Limited (6078.HK) - the largest HK IPO in healthcare industry in 2020.

  • Capital markets

  • Media and entertainment
  • Pharmaceuticals and life sciences
  • Real estate
  • Technology and telecommunications

  • LL.B., Peking University Law School (2001)
  • LL.M., Temple University Law School (2003)